home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

Keeping Drugs Stable Without Refrigeration

  June, 22 2004 8:05
your information resource in human molecular genetics
A spoonful of sugar may help the medicine go down, but it may take only a thin coating of freeze-dried sugar to keep insulin, vaccines and other heat-sensitive, protein-based drugs working reliably even when stored at room temperature and above. Widespread availability of stable, room-temperature therapeutic proteins and vaccines would lower the cost and increase the convenience of these drugs, and could dramatically improve distribution in areas of developing nations where refrigeration may be limited.

New measurements taken by National Institute of Standards and Technology (NIST) scientists and published in the June edition of Biophysical Journal show that rapidly solidified sugars preserve such proteins best when they suppress tiny, molecular motions lasting a nanosecond or less. NIST scientists Christopher Soles and Marcus Cicerone used instruments at the NIST Center for Neutron Research to help them view nanoscale molecular motions of sugar mixtures that were designed to encase proteins. They found a striking correlation between sugar mixtures that provide unusually good protein stabilization and a suppression of very fast motions in the sugars.

Scientists have known for more than a decade that “glassy” sugars can preserve medicines by encasing the proteins in a protective coating. The NIST measurements show that tiny molecular “wiggling” that facilitates protein degradation occurs at time and length scales smaller than once thought to matter. They found that diluting sugars that become “glassy” at a relatively high temperature with the right amount of glycerol formed a stiffer material, further restricting the protein’s movement. It's as though the sugar glove is now made of cement instead of cloth, says Cicerone.

WWW: http://www.nist.gov/

(c) 2004, NIST

Message posted by: Frank S. Zollmann

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2021 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.